Literature DB >> 12658751

Low and maternal-specific expression of p57KIP2 in hydatidiform mole and its clinical implication.

Yali Xiong1, Yang Cao, Hongfa Li.   

Abstract

In situ hybridization was applied to locate and detect the expression of p57KIP2 in hydatidiform mole (5 cases of partial hydatidiform mole and 18 cases of complete hydatidiform mole) and normal villi (23 cases). The positive signals of p57KIP2 expression were analyzed by HPIAS-1000 Image-Analysis System. p57KIP2 was highly expressed in normal villi but showed distinct low expression in hydatidiform mole (P < 0.01). Furthermore, the locus of low expression of p57KIP2 accorded with the place where lesion of trophoblast occurred. Detection of p57KIP2 made it possible to study the genetics of hydatidiform mole at the transcriptional level. Low expression of p57KIP2 could be a molecular marker in hydatidiform mole and a target for therapy.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12658751     DOI: 10.1007/BF02857671

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  6 in total

1.  p57(KIP2) is not mutated in hepatoblastoma but shows increased transcriptional activity in a comparative analysis of the three imprinted genes p57(KIP2), IGF2, and H19.

Authors:  W Hartmann; A Waha; A Koch; C G Goodyer; S Albrecht; D von Schweinitz; T Pietsch
Journal:  Am J Pathol       Date:  2000-10       Impact factor: 4.307

Review 2.  The role of genomic imprinting in implantation.

Authors:  R Goshen; Z Ben-Rafael; B Gonik; O Lustig; V Tannos; N de-Groot; A A Hochberg
Journal:  Fertil Steril       Date:  1994-11       Impact factor: 7.329

3.  A novel human homologue of yeast nucleosome assembly protein, 65 kb centromeric to the p57KIP2 gene, is biallelically expressed in fetal and adult tissues.

Authors:  R J Hu; M P Lee; L A Johnson; A P Feinberg
Journal:  Hum Mol Genet       Date:  1996-11       Impact factor: 6.150

4.  Genomic imprinting of human p57KIP2 and its reduced expression in Wilms' tumors.

Authors:  I Hatada; J Inazawa; T Abe; M Nakayama; Y Kaneko; Y Jinno; N Niikawa; H Ohashi; Y Fukushima; K Iida; C Yutani; S Takahashi; Y Chiba; S Ohishi; T Mukai
Journal:  Hum Mol Genet       Date:  1996-06       Impact factor: 6.150

5.  p57K1P2 is expressed in Wilms' tumor with LOH of 11p15.5.

Authors:  M L Overall; J Spencer; M Bakker; M Dziadek; P J Smith
Journal:  Genes Chromosomes Cancer       Date:  1996-09       Impact factor: 5.006

6.  Selective maternal-allele loss in human lung cancers of the maternally expressed p57KIP2 gene at 11p15.5.

Authors:  M Kondo; S Matsuoka; K Uchida; H Osada; M Nagatake; K Takagi; J W Harper; T Takahashi; S J Elledge; T Takahashi
Journal:  Oncogene       Date:  1996-03-21       Impact factor: 9.867

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.